Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Context Capital Management
Quarter-by-quarter ownership of Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by Context Capital Management
from 13F filings
Historical chart of Context Capital Management investment in Intercept Pharmaceuticals In Note 2.000 5/1 bnd
Tip: Access up to 7 years of quarterly data
All positions including Intercept Pharmaceuticals In Note 2.000 5/1 bnd held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intercept Pharmaceuticals In Note 2.000 5/1 bnd by Context Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $23M | 23k | 979.89 |
2023-06-30 | $16M | 20k | 804.20 |
2023-03-31 | $17M | 20k | 826.84 |
2022-12-31 | $17M | 23k | 766.48 |
2022-09-30 | $14M | 19k | 747.89 |
2022-06-30 | $6.3M | 9.8k | 641.25 |
2021-03-31 | $5.2M | 8.0k | 655.73 |
2020-12-31 | $4.5M | 7.5M | 0.60 |
2020-09-30 | $5.1M | 7.5M | 0.69 |
2020-06-30 | $1.4M | 2.0M | 0.72 |
2020-03-31 | $863k | 985k | 0.88 |
2019-12-31 | $4.6M | 3.5M | 1.32 |
2019-09-30 | $4.5M | 5.0M | 0.90 |
2019-06-30 | $2.5M | 2.5M | 0.99 |
More positions owned by Context Capital Management
View all positions for Context Capital Management
Top funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd
View all funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd